Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-18 07:02 am Purchase |
2021-12-31 | 13G | Adaptimmune Therapeutics plc ADAP |
BAILLIE GIFFORD & CO | 82,538,112 8.810% |
20,391,432 (+32.81%) |
Filing History |
| 2021-02-16 4:08 pm Purchase |
2020-12-31 | 13G | Adaptimmune Therapeutics plc ADAP |
Baker Bros. Advisors LP | 58,985,262 6.400% |
58,985,262 (New Position) |
Filing History |
| 2021-02-16 11:42 am Purchase |
2021-02-16 | 13G | Adaptimmune Therapeutics plc ADAP |
Capital World Investors | 48,016,200 5.200% |
48,016,200 (New Position) |
Filing History |
| 2021-02-16 10:03 am Purchase |
2020-12-31 | 13G | Adaptimmune Therapeutics plc ADAP |
Matrix Capital Management Company, LP | 233,845,110 25.180% |
65,845,110 (+39.19%) |
Filing History |
| 2021-01-28 06:36 am Purchase |
2020-12-31 | 13G | Adaptimmune Therapeutics plc ADAP |
BAILLIE GIFFORD & CO | 62,146,680 6.690% |
62,146,680 (New Position) |
Filing History |